勇敢之心生物 BRVE
$18.60 +$1.19 (+6.80%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $18.60 0.00%
开盘$17.55
昨收$17.42
当日区间$16.89 – $18.99
成交量702.1K
市值$1.67B
市盈率（TTM）–
股息率–
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例72.3%+72.28 个百分点，较上季度
持仓机构数16+16 ，较上季度
内部人近期交易22次买入 / 0次卖出净买入
空头持仓比例5.45% 占流通股回补天数 11.8 · 截至 15 Oct 2026
卖空成交量占比20.6%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：+$1.07M（13个净流入日，7个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有73.5%的流通股。
最大股东
按投资者类型
过去5次双周报告中（14 Aug 2026至15 Oct 2026），空头持仓占流通股比例已从1.20%升至5.45%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| Charles Schwab Investment Management | Mutual Fund | 2026/Q3 | +129,720 | 0.2% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +1,131,988 | 1.4% |
| FMR | Mutual Fund | 2026/Q3 | +633,660 | 0.8% |
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q3 | +182,118 | 0.2% |
| Geode Capital Management, LLC | Mutual Fund | 2026/Q3 | +17,253 | 0.0% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +9,111 | 0.0% |
| OrbiMed Advisors LLC | VC/PE Fund | 2026/Q3 | +12,175,159 | 14.9% |
| BlackRock | Mutual Fund | 2026/Q3 | +132,958 | 0.2% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +52,571 | 0.1% |
| Hartford Funds Management Company, LLC | Mutual Fund | 2026/Q3 | +6,600 | 0.0% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +1,076 | 0.0% |
| Wellington Management Group | Mutual Fund | 2026/Q3 | +900 | 0.0% |
| Vanguard Global Advisers, LLC | Mutual Fund | 2026/Q3 | +520 | 0.0% |
| Forbion Capital Partners B.V. | VC/PE Fund | 2026/Q3 | +21,826,024 | 26.7% |
| Andreessen Horowitz LLC | VC/PE Fund | 2026/Q3 | +10,232,420 | 12.5% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 6 Aug 2026 | OrbiMed Advisors LLC | Private Acquisition | +1,940,000 | $18.00 | 12,175,159 | |
| 6 Aug 2026 | OrbiMed Advisors LLC | Derivative Exercise and Retained | +9,132,420 | – | 12,175,159 | |
| 6 Aug 2026 | David Lubner | Independent Director | Private Acquisition | +55,555 | $18.00 | 55,555 |
| 6 Aug 2026 | Christopher Viehbacher | Independent Chairperson | Private Acquisition | +83,333 | $18.00 | 609,519 |
| 6 Aug 2026 | Jiangsu Hengrui Pharmaceuticals Co.,Ltd | Derivative Exercise and Retained | +7,420,091 | – | 7,420,091 | |
| 6 Aug 2026 | Forbion Capital Partners B.V. | Private Acquisition | +3,600,000 | $18.00 | 21,826,024 | |
| 6 Aug 2026 | Forbion Capital Partners B.V. | Derivative Exercise and Retained | +17,123,287 | – | 21,826,024 | |
| 6 Aug 2026 | Andreessen Horowitz LLC | Private Acquisition | +1,100,000 | $18.00 | 10,232,420 | |
| 6 Aug 2026 | Andreessen Horowitz LLC | Derivative Exercise and Retained | +9,132,420 | – | 10,232,420 | |
| 6 Aug 2026 | Andreessen Horowitz LLC | Initial Statement of Beneficial | +0 | – | 10,232,420 | |
| 6 Aug 2026 | David Malek | Director | Private Acquisition | +4,166 | $18.00 | 1,013,297 |
| 6 Aug 2026 | James Rickey | Chief Financial Officer | Private Acquisition | +27,777 | $18.00 | 703,575 |
| 6 Aug 2026 | Michele Anderson | Chief Development Officer | Private Acquisition | +1,111 | $18.00 | 332,161 |
| 6 Aug 2026 | Travis Murdoch | Chief Executive Officer | Private Acquisition | +83,333 | $18.00 | 8,333,637 |
| 4 Aug 2026 | OrbiMed Advisors LLC | Initial Statement of Beneficial | +0 | – | 1,102,739 | |
| 4 Aug 2026 | David Lubner | Independent Director | Other Derivative Acquisition | +60,000 | $18.00 | 60,000 |
| 4 Aug 2026 | Christopher Viehbacher | Independent Chairperson | Other Derivative Acquisition | +30,000 | $18.00 | 30,000 |
| 4 Aug 2026 | Christopher Viehbacher | Independent Chairperson | Initial Statement of Beneficial | +0 | – | 676,524 |
| 4 Aug 2026 | Erez Chimovits | Independent Director | Other Derivative Acquisition | +30,000 | $18.00 | 30,000 |
| 4 Aug 2026 | Jiangsu Hengrui Pharmaceuticals Co.,Ltd | Initial Statement of Beneficial | +0 | – | 7,420,091 |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 4,905,289 | 5.4% | 11.8 |
| 30 Sep 2026 | 4,128,974 | 4.6% | 5.1 |
| 15 Sep 2026 | 2,461,086 | 2.7% | 7.5 |
| 31 Aug 2026 | 1,397,189 | 2.0% | 5.6 |
| 14 Aug 2026 | 847,773 | 1.2% | 1.3 |
暂无评论——快来第一个聊聊 BRVE。
登录后参与讨论。